Cargando…
Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression
A complex pathogenesis involving several physiological systems is theorized to underline the development of depressive disorders. Depression is accompanied by circadian regulation disruption and interaction with the functioning of both central and peripheral oscillators. Many aspects of melatonin fu...
Autores principales: | Boiko, Dmytro I., Shkodina, Anastasiia D., Hasan, Mohammad Mehedi, Bardhan, Mainak, Kazmi, Syeda Kanza, Chopra, Hitesh, Bhutra, Prerna, Baig, Atif Amin, Skrypnikov, Andrii M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187850/ https://www.ncbi.nlm.nih.gov/pubmed/35689787 http://dx.doi.org/10.1007/s11064-022-03646-5 |
Ejemplares similares
-
Circadian rhythm disorder and anxiety as mental health complications in post-COVID-19
por: Boiko, Dmytro I., et al.
Publicado: (2022) -
Healthcare system amidst the war in Ukraine
por: Shkodina, Anastasiia D., et al.
Publicado: (2022) -
Increased subsequent risk of mental disorders after experiencing stress-related disorders: correspondence
por: Boiko, Dmytro I., et al.
Publicado: (2023) -
The Uterine Melatonergic Systems of AANAT and Melatonin Membrane Receptor 2 (MT2) Are Essential for Endometrial Receptivity and Early Implantation in Mice
por: Ma, Xiao, et al.
Publicado: (2023) -
Melatonergic drugs in development
por: Carocci, Alessia, et al.
Publicado: (2014)